ADVFN US – Market Content Editor

  • Twist Bioscience shares jump 5% after revenue tops forecasts and outlook is lifted

    Twist Bioscience shares jump 5% after revenue tops forecasts and outlook is lifted

    Twist Bioscience Corporation (NASDAQ:TWST) reported fiscal first-quarter 2026 revenue that came in ahead of market expectations on Monday, prompting a rally in the stock, even though earnings fell short of forecasts. Shares of the biotech group were up about 5.16% in premarket trading following the announcement. Twist posted quarterly revenue of $103.7 million for the…

  • Tyson Foods tops Q1 forecasts as prepared foods and chicken drive results

    Tyson Foods tops Q1 forecasts as prepared foods and chicken drive results

    Tyson Foods, Inc. (NYSE:TSN) delivered a stronger-than-expected first quarter, with both adjusted earnings and revenue coming in ahead of forecasts, supported by solid momentum in its prepared foods business and continued market share gains in chicken. The food producer reported adjusted earnings per share of $0.97, beating the consensus estimate of $0.93. Revenue rose 5.1%…

  • Leerink cuts BioNTech to “market perform” after shares surge 24%

    Leerink cuts BioNTech to “market perform” after shares surge 24%

    BioNTech SE (F:22UAy) (NASDAQ:BNTX) has been downgraded to “market perform” from “outperform” by Leerink Partners after a strong share price rally brought the stock closer to its near-term fundamental value. Leerink set a price target of $113 in a note published Monday, a move that sent BioNTech shares down more than 2%. The downgrade follows…

  • Aquestive shares jump despite FDA setback for Anaphylm

    Aquestive shares jump despite FDA setback for Anaphylm

    Aquestive Therapeutics (NASDAQ:AQST) shares surged 18% on Monday even after the company disclosed that it had received a complete response letter (CRL) from the U.S. Food and Drug Administration for Anaphylm, its sublingual film treatment for Type I allergic reactions, including anaphylaxis. The FDA’s feedback focused narrowly on packaging and administration-related concerns, particularly shortcomings identified…

  • Alliance Resource Partners tops Q4 profit forecasts but falls short on revenue

    Alliance Resource Partners tops Q4 profit forecasts but falls short on revenue

    Alliance Resource Partners, L.P. (NASDAQ:ARLP) reported fourth-quarter earnings on Monday that came in ahead of expectations, even as revenue missed consensus forecasts, helped by lower operating costs and stronger investment income. Units of the coal and minerals producer rose 1.39% in premarket trading following the announcement. Alliance posted net income of $82.7 million for the…

  • Nvidia slide threatens to pressure Wall Street at the open: Dow Jones, S&P, Nasdaq, Futures

    Nvidia slide threatens to pressure Wall Street at the open: Dow Jones, S&P, Nasdaq, Futures

    U.S. stock index futures are signaling a weaker start to Monday’s session, pointing to potential losses after markets ended last week on a mixed footing. A key drag on sentiment is a decline in Nvidia (NASDAQ:NVDA), with shares of the AI heavyweight down about 1.6% in premarket trading. The move follows a Wall Street Journal…

  • Revvity delivers Q4 beat as earnings and revenue top forecasts

    Revvity delivers Q4 beat as earnings and revenue top forecasts

    Revvity, Inc. (NYSE:RVTY) reported better-than-expected fourth-quarter results on Monday, with both earnings and revenue coming in ahead of market forecasts. The company posted adjusted earnings per share of $1.70 for the quarter, comfortably above analyst expectations of $1.55. Revenue reached $772.06 million, also exceeding the consensus estimate of $758.53 million. Revvity shares rose 1.05% in…

  • IDEXX Laboratories tops revenue forecasts, shares edge lower on outlook

    IDEXX Laboratories tops revenue forecasts, shares edge lower on outlook

    IDEXX Laboratories (NASDAQ:IDXX) posted a solid set of fourth-quarter results on Monday, with revenue rising 14% to $1.09 billion, beating analyst estimates of $1.07 billion, helped by strong momentum in its companion animal diagnostics operations. Despite the revenue beat, IDEXX shares slipped 0.37% in premarket trading after the release. The company’s guidance for 2026 was…

  • Tesla’s European sales slide further at the start of 2026

    Tesla’s European sales slide further at the start of 2026

    Tesla Inc. (NASDAQ:TSLA) began 2026 facing ongoing weakness across several major European markets, with vehicle registrations falling sharply in January. In France, Tesla registrations dropped 42% last month to just 661 vehicles, their lowest level in more than three years, according to figures published Sunday by the country’s automotive body PFA. The downturn was even…

  • Napco Security Technologies shares jump nearly 6% after strong Q2 beat

    Napco Security Technologies shares jump nearly 6% after strong Q2 beat

    Napco Security Technologies (NASDAQ:NSSC) shares surged almost 6% in premarket trading on Monday after the company reported fiscal second-quarter results that came in well ahead of expectations, supported by robust growth in recurring service revenue and improving margins. The security systems maker posted adjusted earnings of $0.38 per share for the quarter ended December 31,…